Spanish Survey on Third Wave of COVID-19

December 10, 2020 updated by: Beatriz-María Bermejo-Gil, University of Salamanca

COVID-19, the Third Wave Update People Coping With the COVID-19. A Cross-sectional Online Spanish Survey

Due to the pandemic situation, a rapid online survey may be the best method to assess and track people's pandemic cooping. Regarding the huge media influence and the government's restrictions to control the spread of covid-19; it is needed to know more about people's perception and situation to conduct future contentions plans. This study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic. The survey will be delivered to 1000 participants to obtain a representative sample. It would be divided into six sections (general information, demography data, social and consuming habits, Covi-19 question, questions for Covid-19 positive, and questions for Covid-19 negative).

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Salamanca, Spain, 37007
        • Universidad de Salamanca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The sample was selected from the Spanish community population

Description

Inclusion Criteria:

  • Owning online connection
  • Ability to answer and complete the survey

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
What's your work or study system nowadays?
Time Frame: 20 seconds
Multiple choice questionnaire
20 seconds
Habits before the Covid-19 pandemic
Time Frame: 60 seconds
Likert scale questionnaire
60 seconds
Habits in the Covid-19 pandemic
Time Frame: 60 seconds
Likert scale questionnaire
60 seconds
Personal Covid-19 exposure and disease
Time Frame: 10 seconds
Dichotomous options questionnaire
10 seconds
Positive Covid-19: tests, diagnosis, symptoms and quarantine
Time Frame: 60 seconds
Multiple choice questionnaire
60 seconds
Negative Covid-19: tests and quarantine
Time Frame: 40 seconds
Multiple choice questionnaire
40 seconds
Expectations
Time Frame: 10 seconds
Multiple choice questionnaire
10 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Date of birth
Time Frame: 20 seconds
It is registered in the survey to know the age
20 seconds
Sex
Time Frame: 20 seconds
It is registered in the survey
20 seconds
Height
Time Frame: 20 seconds
It is registered in centimeters
20 seconds
Weight
Time Frame: 20 seconds
It is registered in kilograms
20 seconds
Blood type
Time Frame: 20 seconds
Multiple choice questionnaire
20 seconds
Pathologic history
Time Frame: 20 seconds
Multiple choice questionnaire
20 seconds
Region of residence
Time Frame: 20 seconds
Multiple choice questionnaire
20 seconds
City of residence
Time Frame: 20 seconds
Multiple choice questionnaire
20 seconds
Rural or urban environment
Time Frame: 20 seconds
Dichotomous options questionnaire
20 seconds
Cohabitants in the family unit
Time Frame: 20 seconds
The number of cohabitants is registered in the survey
20 seconds

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Salamanca

Investigators

  • Principal Investigator: Beatriz M Bermejo-Gil, Professor, University of Salamanca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

December 9, 2020

Primary Completion (ANTICIPATED)

December 20, 2020

Study Completion (ANTICIPATED)

December 20, 2020

Study Registration Dates

First Submitted

December 8, 2020

First Submitted That Met QC Criteria

December 8, 2020

First Posted (ACTUAL)

December 9, 2020

Study Record Updates

Last Update Posted (ACTUAL)

December 14, 2020

Last Update Submitted That Met QC Criteria

December 10, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CovidSal01/2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Online survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe